7 Einträge gefunden

1. MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients

   1. Huebner, Hanna
   2. Häberle, Lothar
   3. Müller, Volkmar
   4. Schrader, Iris
   5. Lorenz, Ralf
   6. Forstbauer, Helmut
   7. Fink, Visnja

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial

   1. Trapp, Elisabeth K
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Schneeweiss, Andreas
   5. Mueller, Volkmar
   6. Harbeck, Nadia
   7. Lorenz, Ralf

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment:A Phase 3 Randomized Clinical Trial

   1. Friedl, Thomas W P
   2. Fehm, Tanja
   3. Müller, Volkmar
   4. Lichtenegger, Werner
   5. Blohmer, Jens
   6. Lorenz, Ralf
   7. Forstbauer, Helmut

   2021 - Forschungsinformationssystem des UKE
4. Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial

   1. de Gregorio, Amelie
   2. Häberle, Lothar
   3. Fasching, Peter A
   4. Müller, Volkmar
   5. Schrader, Iris
   6. Lorenz, Ralf
   7. Forstbauer, Helmut

   2020 - Forschungsinformationssystem des UKE
5. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial

   1. Jueckstock, Julia
   2. Rack, Brigitte
   3. Friedl, Thomas W P
   4. Scholz, Christoph
   5. Steidl, Julia
   6. Trapp, Elisabeth
   7. Tesch, Hans

   2016 - Forschungsinformationssystem des UKE - frei zugänglich
6. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients

   1. Rack, Brigitte
   2. Schindlbeck, Christian
   3. Jückstock, Julia
   4. Andergassen, Ulrich
   5. Hepp, Philip
   6. Zwingers, Thomas
   7. Friedl, Thomas W P

   2014 - Forschungsinformationssystem des UKE
7. Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.

   1. Sehouli, Jalid
   2. Stengel, Dirk
   3. Harter, Philipp
   4. Kurzeder, Christian
   5. Belau, Antje
   6. Bogenrieder, Thomas
   7. Markmann, Susanne

   2011 - Forschungsinformationssystem des UKE